We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.
- Authors
Anaissie, Elias J; Coleman, Elizabeth A; Goodwin, Julia A; Kennedy, Robert L; Lockhart, Kimberly D; Stewart, Carol B; Coon, Sharon K; Bailey, Clyde; Barlogie, Bart
- Abstract
Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of this retrospective study was to identify risk factors for VTE in NDMM and evaluate the effectiveness of LMWH.
- Publication
Cancer, 2012, Vol 118, Issue 2, p549
- ISSN
1097-0142
- Publication type
Journal Article
- DOI
10.1002/cncr.26302